Block-Type Bone-Regeneration Scaffold for Sustained BMP-2 Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone regeneration treatments face limitations such as immune responses, disease transmission risks, transient release of growth factors, and difficulty in achieving continuous and consistent bone formation, particularly with synthetic bone agents and biologically active substances like BMPs.
Innovation Solution
A composition comprising a biodegradable synthetic polymer, a biocompatible polymer compound with catechol groups, collagen, and a bioactive substance, which forms a multilayer bone-regeneration scaffold for sustained release and improved bone regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous bone grafting is used, then bone regeneration effectiveness is improved, but surgical complexity and patient burden increase due to secondary surgery
Solution Approach 1:
The patent uses synthetic bone graft materials that serve as temporary scaffolds for bone regeneration. These synthetic grafts are designed to be degraded over time as native bone forms, eliminating the need for autologous bone harvesting while providing sufficient regeneration effectiveness.
Solution Approach 2:
The invention combines synthetic polymer materials with bioactive substances to create composite bone graft materials that provide both structural support and biological functionality, achieving effective bone regeneration without requiring patient's own bone tissue.
2Device complexity
If allogeneic or xenogeneic bone grafting is used, then surgical complexity is reduced, but biocompatibility deteriorates due to immune response risks
Solution Approach 1:
The patent employs synthetic polymer materials with controlled degradation rates and pore structures that mimic natural bone extracellular matrix, creating a biocompatible environment that avoids immune rejection while simplifying surgical procedures.
Solution Approach 2:
By combining biocompatible synthetic polymers with bioactive substances, the invention creates graft materials that are both immunologically inert and biologically active, reducing immune responses while maintaining surgical simplicity.
3Reliability
If BMPs are applied, then bone regeneration capability is improved, but controllability worsens due to difficulty in precisely controlling the amount
Solution Approach 1:
The patent incorporates BMPs into the synthetic bone graft material during manufacturing, pre-loading the scaffold with controlled amounts of growth factors. This preliminary incorporation ensures precise dosage control and sustained release throughout the regeneration process.
Solution Approach 2:
The synthetic bone graft is designed with porous structures that control the release kinetics of incorporated BMPs, allowing for sustained and controllable delivery of the growth factors throughout the bone regeneration process.
4Ease of operation
If synthetic bone agents are used, then ease of operation is improved, but bone tissue regeneration ability deteriorates due to inability to conform to three-dimensional bone shape
Solution Approach 1:
The patent creates three-dimensional porous scaffolds with controlled pore sizes and interconnected structures that replicate the complex architecture of natural bone. This three-dimensional structure provides both ease of surgical application and the biological cues necessary for effective bone tissue regeneration.
Solution Approach 2:
The synthetic bone graft utilizes porous materials with optimized pore sizes, porosity, and interconnectivity to facilitate cell infiltration, vascularization, and bone formation while maintaining structural integrity and ease of surgical handling.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The scaffold provides sustained release of bioactive substances, enhances bone regeneration by promoting osteogenic differentiation, and avoids immune responses, offering a reliable and efficient bone graft material with controlled release characteristics.
Implementation Method 1
a biocompatible polymer compound comprising catechol groups
Implementation Method 2
sustained release of growth factors
Implementation Method 3
biodegradable synthetic polymer
Implementation Method 4
simultaneously achieve osteoinduction and osteoconduction
Implementation Method 5
simultaneously achieve osteoinduction and osteoconduction
Data Source
Figure 1~2
Figure 3~4C
Figure 5~6
AI summary
The present invention relates to a composition for bone regeneration, comprising: a biodegradable synthetic polymer; a biocompatible polymer compound comprising catechol groups; a collagen; and a bioactive substance, and provides a bone-regeneration scaffold comprising the composition for bone regeneration.